Glioma targeted therapy: insight into future of molecular approaches
Central South University · Xiangya Hospital Central South University · +2 more institutions
Abstract
Gliomas are the common type of brain tumors originating from glial cells. Epidemiologically, gliomas occur among all ages, more often seen in adults, which males are more susceptible than females. According to the fifth edition of the WHO Classification of Tumors of the Central Nervous System (WHO CNS5), standard of care and prognosis of gliomas can be dramatically different. Generally, circumscribed gliomas are usually benign and recommended to early complete resection, with chemotherapy if necessary. Diffuse gliomas and other high-grade gliomas according to their molecule subtype are slightly intractable, with necessity of chemotherapy. However, for glioblastoma, feasible resection followed by radiotherapy…
Citation impact
- FWCI
- 109.69
- Percentile
- 100%
- References
- 354
Authors
14- KYKeyang YangCorresponding
Central South University, Xiangya Hospital Central South University
- ZWZhijing Wu
Central South University, Xiangya Hospital Central South University
- HZHao Zhang
Central South University, Xiangya Hospital Central South University
- NZNan Zhang
Central South University, Harbin Medical University, Xiangya Hospital Central South University
- WWWantao Wu
Central South University, Xiangya Hospital Central South University
Topics & keywords
- Temozolomide
- Glioma
- Radiation therapy
- Immunotherapy
- Targeted therapy
- Chemotherapy
- Epidermal growth factor receptor
- Oncology
- Good health and well-being
Funding
- NNNational Natural Science Foundation of ChinaAwards: 2018M633002, 2018JJ3838, 2018SK2101, 82073893, 81703622, 82172685, NO.82073893, 81873635, C2019186
- CSCentral South University
- CPChina Postdoctoral Science FoundationAwards: 81873635, 82073893, 81703622, C2019186, 2018JJ3838, 2018SK2101, 2018M633002
- NSNatural Science Foundation of Hunan ProvinceAwards: 81703622, C2019186, 2018M633002, 81873635, 2018SK2101, 2018JJ3838, 82073893
- PRPostdoctoral Research Foundation of ChinaAward: 2018M633002
- XHXiangya Hospital, Central South UniversityAward: 2018JJ3838